EBITDA $100M is def "possible", but you've not mentioned a timeframe.
Let's just get to +$1 first - without removing items that shouldn't be removed.
Derm needs to at least hold fat. The first 3 months were REALLY strong, month 4, not so much.
Management are doing the right 'things', but if someone is questioning why the share price is taking a breather; let's be realistic, we need to see continual and sustained growth as revenue needs to get well above $400m before we are cashflow POS and EBITDA +
- Forums
- ASX - By Stock
- MYX
- Ann: Mayne Pharma presentation at JP Morgan Healthcare Conference
Ann: Mayne Pharma presentation at JP Morgan Healthcare Conference, page-21
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.40 |
Change
0.140(3.29%) |
Mkt cap ! $374.3M |
Open | High | Low | Value | Volume |
$4.25 | $4.43 | $4.25 | $550.5K | 126.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 522 | $4.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.40 | 306 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 870 | 4.390 |
7 | 1146 | 4.380 |
9 | 3548 | 4.370 |
6 | 2634 | 4.360 |
3 | 974 | 4.350 |
Price($) | Vol. | No. |
---|---|---|
4.400 | 242 | 6 |
4.410 | 1132 | 6 |
4.420 | 805 | 2 |
4.430 | 2882 | 4 |
4.440 | 5477 | 4 |
Last trade - 15.30pm 12/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |